:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Langue:
Publié:	Zenodo 2025
Accès en ligne:	https://doi.org/10.5281/zenodo.14715053
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

FCGRT functions in senescence and transformation.
par: Mamoor, Shahan
Publié: (2025)

Chemokine activation during cellular senescence.
par: Mamoor, Shahan
Publié: (2024)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

Gasdermin activation during lineage specification in the human embryo.
par: Mamoor, Shahan
Publié: (2026)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
par: Mamoor, Shahan
Publié: (2025)

Telomerase control of Xist through Trf2.
par: Mamoor, Shahan
Publié: (2025)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
par: Mamoor, Shahan
Publié: (2026)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
par: Mamoor, Shahan
Publié: (2026)

SSX2IP induction in basal subtype breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: SKP2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
par: Mamoor, Shahan
Publié: (2025)

An expression screen to identify genes important for trastuzumab resistance: Meox2.
par: Mamoor, Shahan
Publié: (2026)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
par: Mamoor, Shahan
Publié: (2025)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
par: Mamoor, Shahan
Publié: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: MAP2K3.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
par: Mamoor, Shahan
Publié: (2026)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
par: Mamoor, Shahan
Publié: (2025)